TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals September 20, 2013
TCL Archive NCI Expects 200 CCP applications; Grand Rapids Workshop To Offer Last Chance to Ask Questions September 24, 1982
TCL Archive AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI. December 14, 2001
TCL Archive SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma September 29, 2006
TCL Archive Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.” December 16, 2005
